CCSVI Clinic is owned and managed by healthcare professionals and specialists who are committed to providing specific services that meet the current needs of the MS population during this time of uncertainty and new hope.
After reviewing hundreds of Doppler Ultrasound screenings of MS patients over the past 3 years, CCSVI Clinic clinicians (and other independent researchers) have concluded that there must be a link between occluded or partially blocked neck veins and MS. Statistically this fact cannot be otherwise or the general population (as control group) would also have the same rate of malformations in the same neck veins, but do not. Furthermore, many MS patients who have had their neck veins widened have noted fewer symptoms of their disease as long as the veins maintain higher patency or optimal blood drainage flow from the central nervous system back to the heart. As a result of this noted benefit, tens of thousands of MS patients from a global population have gone for the ‘Liberation Therapy’ and many more than once. Unfortunately, in a relatively short period of time following their procedure, most MS patients’ neck veins also go back to their original malformed shape that again results in restricted blood drainage and a return of neurological disease symptoms. Patients who have undergone subsequent procedures are subject to acute and permanent venous stenosis or thrombosis.
With the goal being to prevent restenosis, the evidence for an additional intervention that supports the initial ‘liberation’ procedure is compelling from the point of view that it not only supports long-term patency, but because of the later adverse events it can avoid. For example, there is now a new and growing subset of MS patients who have had vein-widening venoplasty multiple times, usually to less beneficial effect each time leading to the later discovery of so much intraluminal scar tissue that by the second, third or fourth attempt at re-opening the veins, the procedure cannot be performed again. Topical amongst this group are vascular grafts, pig vein transplants, etc. The need to remove veins and transplant new grafts because they become occluded indicates that there was ‘over-treatment’ of the veins during the initial venoplasty procedure that eventually led to the formation of scar tissue. This further indicates that there may not be recognition of the fragility of the neck vein structure, especially in patients that already have diagnosed venous disease or CCSVI.
Preliminary but compelling evidence indicates that stromal cells injected through the catheter at the time of the venoplasty prevents the normal healing event cascade and avoids the formation of both thrombin and scar tissue intraluminally. Autologous stromal cells quickly assimilate to the endothelium resulting in a stronger and more durable vein that has now been treated for venous disease (CCSVI). Stronger veins avoid the need for subsequent vein dilation procedures with long-term patency as the result. This could be done anywhere the liberation procedure is performed, because the stromal cells are taken from the patient’s own marrow; separated, washed and purified and infused back into the expanded and remodeled vein directly to the site of injury and inflammation due to venoplasty. CCSVI Clinic supports the Zamboni hypothesis and as each patient is being case studied, the research intends to discover whether there is evidence to support both interventions in sequential combination.
As the growing number of current patients recognize, CCSVI Clinic operates on a non-profit basis and will help as many prospective patients as possible receive services if they cannot afford them. If patients qualify for the case study and want to participate long-term with follow-up at regular intervals post-procedure, in the absence of any other financial support, we intend to make sure that as many people as possible have the ability to choose to improve their future health outcomes by helping them to obtain funding for their procedures. Financial hardship will be considered on a case-by-case basis.